René Groeneveld joins the KEMIEX advisory board to help managing the next level of growth. Since launching trading operations in September 2018, KEMIEX has become the leading trading network and platform for ~4'000 pharmaceutical and nutritional raw materials.
Extensive network and experience in pharmaceutical and chemical industries
René is a seasoned top management consultant in the pharmaceutical and chemical industries and brings extensive experience in marketing, sales and human resources, with a focus on strategy execution, rapid up-scaling, and leadership development for multinational clients but also tech companies and start-ups.
In 2017, his company MTAC was sold to BTS GROUP AB, a leading global strategy implementation firm with 700 professionals in 36 offices headquartered in Sweden. He serves as a Vice President at BTS and is also a member of several management boards across different industries.
René graduated in business administration at University of Cologne, has a law degree from Heinrich-Heine University in Duesseldorf, and a psychology degree from the University of Hagen.
“I am honoured and privileged to join the advisory board and look forward to bringing KEMIEX to the next level” says René Groeneveld.
The CEO of KEMIEX, Pau Franquet adds: “We are very happy to win René Groeneveld for our experienced advisory board. This move adds a new level of expertise and industry experience to our board.”
Swiss-based KEMIEX is an independent premium trade network enabling safe and efficient trade through its pioneering trading platform for high-quality buyers and sellers of active pharmaceutical ingredients (APIs), vitamins and other additives for pharmaceutical, veterinary, food and feed industries.
KEMIEX was launched in strategic partnership with ATRADIUS, one of the world’s leading trade credit insurers, providing credit risk insight and innovative insurance solutions to our members exclusively.
SAFE TRADING, WITH RELIABLE COUNTERPARTIES, WORLDWIDE.